Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Upsher-Smith Laboratories has introduced new formulation of PreNexa Rx prenatal vitamins. The new formulation contains an increased amount of algal-oil, plant-based docosahexaenoic acid (DHA), from 265mg to 300mg and increased vitamin D3, from 170 IU to 400 IU.
Subscribe to our email newsletter
DHA, a key omega-3 fatty acid used throughout the body, helps support fetal and infant brain and eye development. Vitamin D is an essential vitamin for mom’s and baby’s skeletal health.
Wesley Mark Todd, senior director of medical affairs at Upsher-Smith Laboratories, said: “PreNexa is the fastest growing single-capsule prenatal vitamin with plant-based DHA on the market. This new formulation reflects the increasing body of evidence pointing to the important role DHA and vitamin D play in pregnancy, lactation and infancy.”
Upsher-Smith Laboratories is actively pursuing product development opportunities in the therapeutic areas of epilepsy and Parkinson’s disease. Its product portfolio is focused in the areas of women’s health, dermatology, and cardiology.